SuperworthCitius Oncology shares outstanding CTOR
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 107.9M
- On a year earlier
- +50.8%
- more shares
Citius Oncology had 107.9M diluted shares outstanding on average in Q3 FY26, the quarter to Jun 30, 2026.
That is 50.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 78.4M | +12% |
| FY2024 | 69.7M | +3% |
| FY2023 | 67.5M | +3081% |
| FY2022 | 2.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 107.9M | +51% | |
| Q2 FY26 | 100M | +40% | |
| Q1 FY26 | 87.5M | +22% | |
| Q4 FY25 | 78.4M | +12% | |
| Q3 FY25 | 71.6M | +6% | |
| Q2 FY25 | 71.6M | +6% | |
| Q1 FY25 | 71.6M | +6% | |
| Q4 FY24 | 69.7M | +3% | |
| Q3 FY24 | 67.5M | +923% | |
| Q1 FY24 | 67.5M | +923% | |
| Q4 FY23 | 67.5M | +3081% | |
| Q3 FY23 | 6.6M | +340% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Citius Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.